Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives
Using artificial intelligence (AI) to enhance chimeric antigen receptor (CAR)-based therapies’ design, production, and delivery is a novel and promising approach. This review provides an overview of the current applications and challenges of AI for CAR-based therapies and suggests some directions fo...
Saved in:
| Main Authors: | Muqadas Shahzadi, Hamad Rafique, Ahmad Waheed, Hina Naz, Atifa Waheed, Feruza Ravshanovna Zokirova, Humera Khan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Therapeutic Advances in Vaccines and Immunotherapy |
| Online Access: | https://doi.org/10.1177/25151355241305856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric Antigen Receptor T-cell therapy in systemic autoimmune rheumatic diseases: current insights and future prospects
by: Bong-Woo Lee, et al.
Published: (2025-07-01) -
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01) -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01) -
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.
by: Hannah Karlsson, et al.
Published: (2015-01-01) -
Advance in chimeric antigen receptor T therapy in autoimmune diseases
by: Xiaolan Ji, et al.
Published: (2025-03-01)